The slip
PARKINSON RECEIPTno. 0554
17 Oct 2026, 02:30 UTColigodendrocytes, braak
predictionGRIN2D in oligodendrocytes tracks Braak Lewy-body stage
registered6ef82cc0318af5c6
discovery-0.24 p=0.533 n=9
replication-0.16 p=0.682 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.24, p 0.533)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT13c63ab2d4ea625baeac9c41…
follows 445f1ca520cd…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 0554: GRIN2D in oligodendrocytes, braak
- power
- full sample -0.11 (p 0.671, n 18), 95% CI -0.55 to +0.38. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.08 (p 0.748, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.29 (p 0.243, n 18). could be the mix.
- skeptic
- leave-one-out range -0.22 to +0.01, sign flips 3; without severely affected donors -0.11 (p 0.671, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GRIN2D in oligodendrocytes.
case closed: nothing better to follow up.